MOUNJARO Trademark

Trademark Overview

On Tuesday, November 8, 2022, a trademark application was filed for MOUNJARO with the United States Patent and Trademark Office. The USPTO has given the MOUNJARO trademark a serial number of 97668206. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Saturday, June 20, 2026. This trademark is owned by Eli Lilly and Company. The MOUNJARO trademark is filed in the Insurance & Financial Services category with the following description:

Financial assistance in connection with the purchase of pharmaceutical preparations in the field of diabetes, obesity, overweight, and metabolic diseases
mounjaro

General Information

Serial Number97668206
Word MarkMOUNJARO
Filing DateTuesday, November 8, 2022
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateSaturday, June 20, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 2, 2023

Trademark Statements

Goods and ServicesFinancial assistance in connection with the purchase of pharmaceutical preparations in the field of diabetes, obesity, overweight, and metabolic diseases

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, November 28, 2022
Primary Code036
First Use Anywhere DateThursday, June 30, 2022
First Use In Commerce DateThursday, June 30, 2022

Trademark Owner History

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
US
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
US

Trademark Events

Event DateEvent Description
Friday, November 11, 2022NEW APPLICATION ENTERED
Monday, November 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 1, 2023ASSIGNED TO EXAMINER
Friday, February 3, 2023NON-FINAL ACTION WRITTEN
Friday, February 3, 2023NON-FINAL ACTION E-MAILED
Friday, February 3, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 23, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 23, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 12, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 2, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 2, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 27, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 7, 2023SOU EXTENSION 1 FILED
Tuesday, November 7, 2023SOU EXTENSION 1 GRANTED
Thursday, November 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 9, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 9, 2024SOU EXTENSION 2 FILED
Thursday, May 9, 2024SOU EXTENSION 2 GRANTED
Friday, May 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 17, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 17, 2024SOU EXTENSION 3 FILED
Thursday, October 17, 2024SOU EXTENSION 3 GRANTED
Thursday, October 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 5, 2025SOU TEAS EXTENSION RECEIVED
Monday, May 5, 2025SOU EXTENSION 4 FILED
Tuesday, May 6, 2025SOU EXTENSION 4 GRANTED
Tuesday, May 6, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 14, 2025SOU TEAS EXTENSION RECEIVED
Thursday, March 12, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 13, 2025SOU EXTENSION 5 FILED
Monday, March 16, 2026SOU EXTENSION 5 GRANTED
Tuesday, March 17, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 12, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 12, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 12, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 19, 2026TEAS STATEMENT OF USE RECEIVED
Friday, June 19, 2026USE AMENDMENT FILED
Saturday, June 20, 2026STATEMENT OF USE PROCESSING COMPLETE

Related Keywords

mounjaro obesity diabetes overweight metabolic diseases field preparations assistance connection purchase